Dmitry Nemirovsky, MD
Clinical Cardiac Electrophysiology · Englewood, NJNPI 1518086933
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $23,374 of the $37,179 with a category attached, or 62.9%. E.r. Squibb & Sons, L.L.C. accounts for 77.5% of it on its own, with 27 other manufacturers making up the rest.
Across 163 payments — averaging $228.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$29K
- Medtronic$4K
- Abbott$2K
- Boston Scientific$809
- Bristol Myers Squibb$600
- Pfizer$196
- plus $1K from 22 others
Across 4 payments — averaging $8615.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$34K
What the payments were for
- Consulting fees$4,20011%
- Speaking & faculty fees$23,37463%
- Travel & lodging$2,1726%
- Food & beverage$7,43220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 38 | $28,809 |
| Medtronic(2 entities) | 39 | $3,888 |
| Abbott | 25 | $1,654 |
| Boston Scientific | 13 | $809 |
| Bristol Myers Squibb | 2 | $600 |
| Pfizer | 5 | $196 |
| Philips North America LLC | 2 | $183 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $170 |
| Cvrx, Inc. | 1 | $163 |
| Atricure, Inc. | 3 | $151 |
| Cordis US CORP. | 6 | $98 |
| Biosense Webster, Inc. | 2 | $66 |
| Smith+Nephew | 1 | $57 |
| Abiomed | 2 | $41 |
| Biotronik Inc. | 2 | $36 |
| Cardiva Medical, Inc. | 2 | $36 |
| Alnylam Pharmaceuticals Inc. | 2 | $30 |
| Kestra Medical Technology Services, Inc. | 1 | $29 |
| Lundbeck LLC | 2 | $25 |
| Novartis | 1 | $23 |
| Johnson & Johnson | 1 | $18 |
| Bayer | 1 | $17 |
| Angiodynamics, Inc. | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Portola Pharmaceuticals, LLC | 1 | $14 |
| Amgen | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $12 |
| Chiesi USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAMZYOS$23,731
- AVEIR$1,152
- Reveal LINQ$454
- MyCareLink$388
- SureScan$347
- Micra$314
- AURORA EV-ICD MRI SURESCAN$300
- ARCTIC FRONT ADVANCE$250
- EVERA MRI XT DR SURESCAN$209
- CareLink$200
- Barostim Neo System$163
- EMBLEM MRI S-ICD$157
- COBALT DR MRI SURESCAN$155
- SelectSecure$138
- VYNDAQEL$133
- AZURE XT DR MRI SURESCAN$127
- GENERAL - THERAPIES$124
- LINQ II$107
How this compares
$37,179 in reported general payments places this provider in the 75th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
See all clinical cardiac electrophysiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 72 | $79,222 |
| XareltoRivaroxaban | 21 | $27,061 |
| MultaqDronedarone Hcl | 12 | $9,417 |
| Amiodarone Hcl | 72 | $2,938 |
| Dofetilide | 11 | $1,880 |
| Metoprolol Succinate | 93 | $1,715 |
| Flecainide Acetate | 15 | $753 |
| Metoprolol Tartrate | 11 | $64 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $196 | $79,22272 claims |
| Johnson & JohnsonXarelto | $18 | $27,06121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
Other clinical cardiac electrophysiology in Englewood
- Grant SimonsEnglewood$93K
- Benjamin D SouzaCherry Hill$741K
- Suneet MittalParamus$722K
- George MarkHaddon Heights$312K
- Raffaele CorbisieroBrowns Mills$135K
- Emad AzizNewark$112K
- Marc RoelkeWest Orange$110K
- Arjun TheerthamParlin$102K
- Michael LinkGalloway$96K
- Jonathan SteinbergRidgewood$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.